ROBIN SEVERANCE: Open Payments
NPI 1417942848 · FRANKLIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,906 in 94 payments from 18 companies in 2025. Trend: 2023 $2,002 · 2024 $2,178 · 2025 $1,906
Food & beverage: $1,846Education: $60
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 26 | $424 |
| ABBVIE INC. | 19 | $316 |
| Janssen Biotech, Inc. | 10 | $256 |
| UCB, Inc. | 8 | $176 |
| E.R. Squibb & Sons, L.L.C. | 7 | $174 |
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| ANI Pharmaceuticals, Inc. | 3 | $81 |
| Organon LLC | 3 | $72 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Fresenius Kabi USA, LLC | 2 | $45 |
Products named: TREMFYA, RINVOQ, Bimzelx, ORENCIA, KRYSTEXXA, SAPHNELO, SKYRIZI, TAVNEOS.
Industry payments across TN — which companies pay providers there.
